Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure from Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity
  1. Home
  2. Publications
  3. Supplementary Figure from Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

Supplementary Figure from Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

Authors:
  • DPDana Piovesan
    Dana Piovesan
  • JTJoanne B.L. Tan
    Joanne B.L. Tan
  • ABAnnette Becker
    Annette Becker
  • JBJesus Banuelos
    Jesus Banuelos
  • NNNell Narasappa
    Nell Narasappa
  • DDDaniel DiRenzo
    Daniel DiRenzo
  • KZKristen Zhang
    Kristen Zhang
  • ACAda Chen
    Ada Chen
  • EGElaine Ginn
    Elaine Ginn
  • AUAkshata R. Udyavar
    Akshata R. Udyavar
  • FYFangfang Yin
    Fangfang Yin
  • SPSusan L. Paprcka
    Susan L. Paprcka

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.22522341
Abstract
Supplementary Figure from Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity
Keywords
  • FUNCTIONALITY
  • TARGETING CD73
  • FIGURE FROM TARGETING
  • CD73 WITH AB680
  • SUPPLEMENTARY FIGURE
  • ANTITUMOR
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.